UBS Keeps Their Hold Rating on CME Group (CME)

In a report released today, Alex Kramm from UBS maintained a Hold rating on CME Group, with a price target of $310.00.

Easter Sale - 70% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Kramm is a 5-star analyst with an average return of 10.3% and a 60.16% success rate. Kramm covers the Financial sector, focusing on stocks such as Cboe Global Markets, CME Group, and Intercontinental Exchange.

In a report released today, Barclays also maintained a Hold rating on the stock with a $312.00 price target.

Based on CME Group’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.65 billion and a net profit of $1.17 billion. In comparison, last year the company earned a revenue of $1.53 billion and had a net profit of $874.6 million

Based on the recent corporate insider activity of 94 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CME in relation to earlier this year. Last month, Elizabeth Cook, a Director at CME sold 1,000.00 shares for a total of $320,000.00.